Bharat Biotech submits proposal to DGCI for approval of nasal vaccine trials
  • 3 years ago
Bharat Biotech has submitted a proposal to the Drugs Controller General of India (DCGI) to seek its approval for trials of a nasal vaccine against Covid-19.
Recommended